Clinical Development Generic Pharmaceutical Licensing Marketing 
XTalks
AUGUST 2, 2023
We delve into the driving forces behind their successes and shed light on the groundbreaking research that has earned them a place among the elite in the pharmaceutical arena. is a global pharmaceutical company, working across both developed and emerging markets. 2022 Revenue: Pfizer reported an annual revenue of $100.33
The Pharma Data
DECEMBER 23, 2020
company developing UB-612 a multitope peptide-based vaccine to fight COVID-19, today announced an exclusive agreement with Aurobindo Pharma to expand its global development and commercialization of UB-612 to India and the United Nations Children’s Fund (UNICEF) agency. .–( BUSINESS WIRE )– COVAXX, a U.S.
The Pharma Data
DECEMBER 23, 2020
Under the signed agreement, Aurobindo Pharma has obtained the exclusive rights to develop, manufacture and sell COVAXX’s UB-612 vaccine in India and to UNICEF, as well as non-exclusive rights in other select emerging and developing markets. ” About Aurobindo Pharma.
Expert insights. Personalized for you.
98 
Let's personalize your content